Acobiom

ACOBIOM presents GEMCITEST, a molecular able to identify the pancreatic who are most likely to benefit from gemcitabine in first line therapy

https://youtu.be/_gM5ecbwi5A

ACOBIOM presents GEMCITEST GEMCITEST is a molecular diagnostic for Precision Medecine in Pancreatic Cancer.This in-vitro diagnostic is able to analyze the blood of patients suffering f...